Gender and species differences in triadimefon metabolism by rodent hepatic microsomes

Toxicology Letters

Volumn 193, Issue 1, 2010, Pages 101-107

  Crowell, Susan R ^b   Henderson, W Matthew ^a   Fisher, Jeffrey W ^b   Kenneke, John F ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Gender; In vitro half life; KM; Michaelis Menten; Rodent hepatic microsomes; Triadimefon; VMAX

Indexed keywords

TRIADIMEFON; TRIADIMENOL;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL METABOLISM; COMPETITIVE INHIBITION; CONTROLLED STUDY; FEMALE; HALF LIFE TIME; IN VITRO STUDY; LIVER MICROSOME METABOLISM; MALE; MATHEMATICAL MODEL; METABOLIC CLEARANCE RATE; METABOLIC RATE; MICHAELIS CONSTANT; MICHAELIS MENTEN KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SPECIES DIFFERENCE;

ALGORITHMS; ANIMALS; FEMALE; FUNGICIDES, INDUSTRIAL; HALF-LIFE; INDICATORS AND REAGENTS; MALE; MICE; MICROSOMES, LIVER; RATS; RATS, SPRAGUE-DAWLEY; RISK ASSESSMENT; SEX CHARACTERISTICS; SPECIES SPECIFICITY; TRIAZOLES;

MUS; RATTUS; RODENTIA;

EID: 75749150434     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2009.12.011     Document Type: Article

References (30)

1. Allen J.W., Wolf D.C., George M.H., Hester S.D., Sun G., Thai S.F., Delker D.A., Moore T., Jones C., Nelson G., Roop B.C., Leavitt S., Winkfield E., Ward W.O., and Nesnow S. Toxicity profiles in mice treated with hepatotumorigenic and non-hepatotumorigenic triazole conazole fungicides: propiconazole, triadimefon, and myclobutanil. Toxicologic Pathology 34 (2006) 853-862
2. Barton H.A., Tang J., Sey Y.M., Stanko J.P., Murrell R.N., Rockett J.C., and Dix D.J. Metabolism of myclobutanil and triadimefon by human and rat cytochrome P450 enzymes and liver microsomes. Xenobiotica 36 (2006) 793-806
3. Brown R.P., Delp M.D., Lindstedt S.L., Rhomberg L.R., and Belilesi R.P. Physiological parameter values for physiologically based pharmacokinetic models. Toxicology and Industrial Health 13 (1997) 407-484
4. Buchenauer H. Mode of action of triadimefon in Ustilago avenae. Pesticide Biochemistry and Physiology 7 (1977) 309-320
5. Crofton K.M., Boncek V.M., and Reiter L.W. Hyperactivity induced by triadimefon, a triazole fungicide. Fundamental and Applied Toxicology 10 (1988) 459-465
6. Crofton K.M. A structure-activity relationship for the neurotoxicity of triazole fungicides. Toxicology Letters 84 (1996) 155-159
7. FAO/WHO (2004). Pesticide Residues in Food 2004, Evaluations, FAO Plant Production and Protection Paper, 178 pp. 231-241. World Health Organization and Food and Agriculture Organization of the UN, Rome.
8. Goetz A.K., Bao W., Ren H., Schmid J.E., Tully D.B., Wood C., Rockett J.C., Narotsky M.G., Sun G., Lambert G.R., Thai S.F., Wolf D.C., Nesnow S., and Dix D.J. Gene expression profiling in the liver of CD-1 mice to characterize the hepatotoxicity of triazole fungicides. Toxicology and Applied Pharmacology 215 (2006) 274-284
9. Goetz A.K., Ren H., Schmid J.E., Blystone C.R., Thillainadarajah I., Best D.S., Nichols H.P., Strader L.F., Wolf D.C., Narotsky M.G., Rockett J.C., and Dix D.J. Disruption of testosterone homeostasis as a mode of action for the reproductive toxicity of triazole fungicides in the male rat. Toxicological Sciences 95 (2007) 227-239
10. Hurley P.M., Hill R.N., and Whiting R.J. Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents. Environmental Health Perspectives 106 (1998) 437-445
11. INCHEM 1981. Triadimefon (pesticide residues in food: 1981 evaluations) 36 pp. www.inchem.org/documents/jmpr/jmpmono/v81pr32.htm.
12. Kenneke J.F., Mazur C.S., Ritger S.E., and Sack T.J. Mechanistic investigation of the noncytochrome P450-mediated metabolism of triadimefon to triadimenol in hepatic microsomes. Chemical Research in Toxicology 21 (2008) 1997-2004
13. Maser E., and Bannenberg G. 11β-Hydroxysteroid dehydrogenase mediates reductive metabolism of xenobiotic carbonyl compounds. Biochemical Pharmacology 47 (1994) 1805-1812
14. Mazur C.S., Kenneke J.F., Tebes-Stevens C., Okino M.S., and Lipscomb J.C. In vitro metabolism of the fungicide and environmental contaminant trans-bromuconazole and implications for risk assessment. Journal of Toxicology and Environmental Health Part A 70 (2007) 1241-1250
15. Menegola E., Broccia M.L., Di Renzo F., Prati M., and Giavini E. In vitro teratogenic potential of two antifungal triazoles: triadimefon and triadimenol. In Vitro Cell Developmental Biology 36 (2000) 88-95
16. Menegola E., Broccia M.L., Di Renzo F., Massa V., and Giavini E. Craniofacial and axial skeletal defects induced by the fungicide triadimefon in the mouse. Birth Defects Research (Part B) 74 (2005) 185-195
17. Menegola E., Broccia M.L., Di Renzo F., Massa V., and Giavini E. Study on the common teratogenic pathway elicted by the fungicides triazole-derivatives. Toxicology In Vitro 19 (2005) 737-748
18. Mode A., and Gustafsson J.A. Sex and the liver-a journey through five decades. Drug Metabolism Reviews 38 (2006) 197-207
19. Moser V.C., and MacPhail R.C. Neurobehavioral effects of triadimefon, a triazole fungicide, in male and female rats. Neurotoxicology and Teratology 11 (1989) 285-293
20. Mugford C.A., and Kedderis G.L. Sex-dependent metabolism of xenobiotics. Drug Metabolism Reviews 30 (1998) 441-498
21. Obach R.S., Baxter J.G., Liston T.E., Silber B.M., Jones B.C., MacIntyre F., Rance D.J., and Wastall P. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. Pharmacology and Experimental Therapeutics 283 (1997) 46-58
22. Obach R.S. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metabolism and Disposition 27 (1999) 1350-1359
23. Obach R.S., and Reed-Hagen A.E. Measurement of Michaelis constants for cytochrome P450-mediated biotransformation reactions using a substrate depletion approach. Drug Metabolism and Disposition 30 (2002) 831-837
24. Roberts T., and Hutson D. Triadimefon. In: Roberts T., and Hutson D. (Eds). Metabolic pathways of argochemicals. Part two: insecticides and fungicides (1999), The Royal Society of Chemistry, Cambridge, UK 1090-1094
25. Rockett J.C., Narotsky M.G., Thomspon K.E., Thillainadarajah I., Blystone C.R., Goetz A.K., Ren H., Best D.S., Murrell R.N., Nichols H.P., Schmid J.E., Wolf D.C., and Dix D.J. Effect of conazole fungicides on reproductive development in the female rat. Reproductive Toxicology 22 (2006) 647-658
26. Ronis M.J.J., Ingelman-Sundberg M., and Badger T.M. Induction, suppression and inhibition of multiple hepatic cytochrome P450 isozymes in the male rat and bobwhite quail (Colinus virginianus) by ergosterol biosynthesis inhibiting fungicides (EBIFs). Biochemical Pharmacology 48 (1994) 1953-1965
27. United States Environmental Protection Agency. Triadimefon (Bayleton) pesticide tolerance. Federal Register 62 (1996) 47005-47013
28. United States Environmental Protection Agency. Re-registration eligibility decision for triadimefon and triadimenol and tolerance reassessment for triadimenol (2006), Office of Pesticide Programs, U.S. Environmental Protection Agency, Washington, DC
29. Walker Q.D., Lewis M.H., Crofton K.M., and Mailman R.B. Triadimefon, a triazole fungicide, induces stereotyped behavior and alters monoamine metabolism in rats. Toxicology and Applied Pharmacology 102 (1990) 474-485
30. Zarn J.A., Bruschweiler B.J., and Schlatter J.R. Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14a-demethylase and aromatase. Environmental Health Perspectives 111 (2003) 255-261